REBECCA LEE: Open Payments
NPI 1417340589 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$259 in 9 payments from 6 companies in 2025. Trend: 2023 $1,064 · 2024 $663 · 2025 $259
Food & beverage: $259
| Company | Payments | Amount |
|---|---|---|
| UCB, Inc. | 2 | $116 |
| ABBVIE INC. | 3 | $61 |
| Madrigal Pharmaceuticals | 1 | $26 |
| Aimmune Therapeutics, Inc. | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Phathom Pharmaceuticals, Inc. | 1 | $14 |
Products named: Bimzelx, REZDIFFRA, RINVOQ, ZENPEP, CREON, EBGLYSS, LINZESS, VOQUEZNA.
Industry payments across AR — which companies pay providers there.
